Better Choice Company And 2 Other Stocks Under $3 Insiders Are Buying
Better Choice Company And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed lower by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週一收盤下跌超過250點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
Sharps Technology
夏普斯科技
- The Trade: Sharps Technology, Inc. (NASDAQ:STSS) CEO Robert Michael Hayes acquired a total of 10,200 shares an average price of $0.36. To acquire these shares, it cost around $3,646.
- What's Happening: Sharps Technology signed a LOI with Roncadelle Operations enabling the companies to cooperatively sell and distribute each other's productive.
- What Sharps Technology Does: Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa ultra-low waste smart safety syringes are designed to eliminate over two million potentially infectious and accidental needlestick injuries.
- 交易：夏普斯科技公司（納斯達克股票代碼：STSS）首席執行官羅伯特·邁克爾·海斯 共收購了 10,200 股股票 平均價格爲0.36美元。收購這些股票的成本約爲3,646美元。
- 發生了什麼：夏普斯科技與Roncadelle Operations簽署了意向書，使兩家公司能夠合作銷售和分配彼此的產品。
- 夏普斯科技做什麼：夏普斯科技公司是一家醫療器械公司。它提供注射器和其他安全產品。Sharps provensa 超低浪費智能安全注射器旨在消除超過 200 萬種潛在的傳染性和意外針刺傷害。
Better Choice Company
更好的選擇公司
- The Trade: Better Choice Company Inc. (NYSE:BTTR) Director
- Michael Young acquired a total of 1.14 million shares at at an average price of $0.20. To acquire these shares, it cost around $102,578.
- What's Happening: Better Choice, during November, posted a narrower-than-expected third-quarter loss.
- What Better Choice Company Does: Better Choice Co Inc is a pet health and wellness portfolio company, offering consumers a wide variety of recognized premium pet products and hemp-derived CBD supplements.
- 貿易：Better Choice Company Inc.（紐約證券交易所代碼：BTTR）董事
- 邁克爾·楊 共收購了114萬股股票 平均價格爲0.20美元。收購這些股票的成本約爲102,578美元。
- 發生了什麼：Better Choice在11月公佈的第三季度虧損低於預期。
- Better Choice公司的所作所爲：Better Choice Co Inc是一家寵物健康和保健投資組合公司，爲消費者提供各種公認的優質寵物產品和大麻衍生的CBD補充劑。
Check This Out: Cramer Expects Drugmaker Stock To Go 'Even Higher,' As For Kroger: 'What The Heck Is Going On?'
看看這個： 克萊默預計製藥商的股票將 “進一步走高”，至於克羅格：“到底發生了什麼？”
Arcadia Biosciences
阿卡迪亞生物科學
- The Trade: Arcadia Biosciences, Inc. (NASDAQ:RKDA) CFO Thomas J. Schaefer acquired a total of 700 shares at an average price of $2.06. The insider spent around $1,442 to buy those shares.
- What's Happening: Arcadia Biosciences, during November, posted a narrower-than-expected quarterly loss.
- What Arcadia Biosciences Does: Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products.
- 交易：阿卡迪亞生物科學公司（納斯達克股票代碼：RKDA）首席財務官托馬斯·舍費爾 共收購了700股股票 平均價格爲2.06美元。知情人士花費了約1,442美元購買了這些股票。
- 發生了什麼：Arcadia Biosciences在11月公佈的季度虧損低於預期。
- 阿卡迪亞生物科學公司做什麼：阿卡迪亞生物科學公司是創新的植物性食品和飲料產品的生產商和銷售商。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。